Vaccination perception and coverage among healthcare students in France in 2019.
Healthcare students
Vaccination coverage
Vaccination hesitancy
Vaccination perception
Journal
BMC medical education
ISSN: 1472-6920
Titre abrégé: BMC Med Educ
Pays: England
ID NLM: 101088679
Informations de publication
Date de publication:
14 Dec 2020
14 Dec 2020
Historique:
received:
08
07
2020
accepted:
06
12
2020
entrez:
15
12
2020
pubmed:
16
12
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Vaccine hesitancy in healthcare workers has been increasing especially in France while they are the cornerstone of vaccination programs. Greater understanding of healthcare students (HCS) vaccine knowledge, attitudes and beliefs is necessary to provide an adequate vaccination education to better equip them to promote vaccination in their future careers. The aim of this study was to assess vaccination perception (VP) (perception of benefits and risks of vaccines) and its impact on vaccination coverage (VC) for mandatory and recommended vaccines among HCS. A standardized, anonymous self-reporting electronic questionnaire was prospectively sent to HCS (medicine, nursing, pharmacy, midwifery, physiotherapy students and 1st year of health sciences students) of Normandy University in France between 18/03/2019 and 8/04/2019. VP was evaluated with questions regarding vaccination hesitancy, safety of vaccine and the benefit/risk balance of vaccination. Global VC (GVC) was defined as being vaccinated according to the mandatory and/or recommended vaccination schedule by national French law in 2018. 542 HCS took part in this survey. VC was high for mandatory (diphtheriae, poliomyelitis, tetanus 93.5%, hepatitis B virus 88.6%) and even most of recommended vaccinations (measles 95%, pertussis 88.2%). Global VC (40.4%) was not statistically different between HCS except for 1st year health sciences students who were less vaccinated (25.6%). Regarding VP, 97.8% of HCS thought that vaccine are effective. When vaccine safety and level of vaccine hesitancy were assessed (on a 0-10 scale, 0: not safe or not hesitant and 10: completely safe and strongly hesitant for vaccine), 91% of respondents stated that vaccine safety is ≥7 and in 80% the vaccine hesitancy was < 3. There was no difference among student categories. 80.6% of HCS recommended all vaccines but only 52% agreed that flu vaccination should be mandatory for HCS. In the multivariate analysis, being a 1st year health care sciences student was associated with a lower GVC (OR 95% CI = 2 [1.2-3.3], p = 0.004) than being a medical student. HCS perceived vaccine as effective and secure. Despite the good perception of vaccines, less than half HCS are well vaccinated.
Sections du résumé
BACKGROUND
BACKGROUND
Vaccine hesitancy in healthcare workers has been increasing especially in France while they are the cornerstone of vaccination programs. Greater understanding of healthcare students (HCS) vaccine knowledge, attitudes and beliefs is necessary to provide an adequate vaccination education to better equip them to promote vaccination in their future careers. The aim of this study was to assess vaccination perception (VP) (perception of benefits and risks of vaccines) and its impact on vaccination coverage (VC) for mandatory and recommended vaccines among HCS.
METHODS
METHODS
A standardized, anonymous self-reporting electronic questionnaire was prospectively sent to HCS (medicine, nursing, pharmacy, midwifery, physiotherapy students and 1st year of health sciences students) of Normandy University in France between 18/03/2019 and 8/04/2019. VP was evaluated with questions regarding vaccination hesitancy, safety of vaccine and the benefit/risk balance of vaccination. Global VC (GVC) was defined as being vaccinated according to the mandatory and/or recommended vaccination schedule by national French law in 2018.
RESULTS
RESULTS
542 HCS took part in this survey. VC was high for mandatory (diphtheriae, poliomyelitis, tetanus 93.5%, hepatitis B virus 88.6%) and even most of recommended vaccinations (measles 95%, pertussis 88.2%). Global VC (40.4%) was not statistically different between HCS except for 1st year health sciences students who were less vaccinated (25.6%). Regarding VP, 97.8% of HCS thought that vaccine are effective. When vaccine safety and level of vaccine hesitancy were assessed (on a 0-10 scale, 0: not safe or not hesitant and 10: completely safe and strongly hesitant for vaccine), 91% of respondents stated that vaccine safety is ≥7 and in 80% the vaccine hesitancy was < 3. There was no difference among student categories. 80.6% of HCS recommended all vaccines but only 52% agreed that flu vaccination should be mandatory for HCS. In the multivariate analysis, being a 1st year health care sciences student was associated with a lower GVC (OR 95% CI = 2 [1.2-3.3], p = 0.004) than being a medical student.
CONCLUSION
CONCLUSIONS
HCS perceived vaccine as effective and secure. Despite the good perception of vaccines, less than half HCS are well vaccinated.
Identifiants
pubmed: 33317501
doi: 10.1186/s12909-020-02426-5
pii: 10.1186/s12909-020-02426-5
pmc: PMC7734903
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
508Références
Med Mal Infect. 2013 Mar;43(3):114-7
pubmed: 23498136
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Pediatrics. 2008 Oct;122(4):718-25
pubmed: 18829793
Emerg Infect Dis. 2011 Sep;17(9):1766-7
pubmed: 21888820
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Eur J Public Health. 2019 Feb 1;29(1):2-8
pubmed: 30085024
Vaccine. 2013 Jun 10;31(26):2835-8
pubmed: 23623864
Lancet. 2018 Sep 1;392(10149):724
pubmed: 30191821
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Clin Ter. 2019 Nov-Dec;170(6):e448-e453
pubmed: 31696908
BMC Med Educ. 2019 Jul 2;19(1):242
pubmed: 31266481
Vaccine. 2017 Oct 27;35(45):6059-6069
pubmed: 28974409
Vaccine. 2016 Sep 22;34(41):5013-5020
pubmed: 27576074
BMC Public Health. 2017 Jul 7;17(1):634
pubmed: 28687075
Clin Microbiol Infect. 2012 May;18(5):E137-9
pubmed: 22404767
Vaccine. 2009 Jun 24;27(31):4240-3
pubmed: 19481314
Emerg Infect Dis. 2013 Mar;19(3):357-64
pubmed: 23618523
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
J Hosp Infect. 2013 May;84(1):38-43
pubmed: 23433868
Euro Surveill. 2016 Nov 24;21(47):
pubmed: 27918262
Med Mal Infect. 2019 Feb;49(1):34-37
pubmed: 30409542
Vaccine. 2010 Jun 11;28(26):4235-48
pubmed: 20438879
Vaccine. 2016 Dec 20;34(52):6700-6706
pubmed: 27810314
PLoS One. 2018 Mar 29;13(3):e0194920
pubmed: 29596515
MMWR Morb Mortal Wkly Rep. 1999 Apr 2;48(12):241-3
pubmed: 10220250
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550
Euro Surveill. 2018 Apr;23(17):
pubmed: 29717693
Hum Vaccin Immunother. 2019;15(3):700-709
pubmed: 30395762
Hum Vaccin Immunother. 2020 May 3;16(5):1125-1131
pubmed: 31809633
BMC Med Educ. 2010 Nov 26;10:86
pubmed: 21110845
Euro Surveill. 2018 Jun;23(25):
pubmed: 29945697
Hum Vaccin Immunother. 2016 Jun 2;12(6):1454-68
pubmed: 26838681
Am J Infect Control. 2005 Oct;33(8):473-5
pubmed: 16216662
Hum Vaccin Immunother. 2015;11(11):2522-37
pubmed: 26291642
Hum Vaccin Immunother. 2016 Sep;12(9):2459-63
pubmed: 27029897
Vaccine. 2014 Aug 27;32(38):4855-9
pubmed: 24503273
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713